Phototherapy Equipment Market (2026 - 2033)

Phototherapy Equipment Market Summary

The global phototherapy equipment market size was valued at USD 800.0 million in 2025 and is projected to grow from USD 900.0 million in 2026 to USD 1,522.0 million in 2033, at a CAGR of 7.8% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 39.0% in 2025. The rising prevalence of skin diseases is the key factor driving the market growth.

For instance, according to the American Academy of Dermatology Association, 84.5 million Americans, i.e., around one in every four individuals are impacted by some kind of skin disease. The rise in neonatal jaundice cases, increasing prevalence of skin disease, influx of technologically sophisticated products, and increasing use of LED-based phototherapy equipment are the primary factors driving the market for phototherapy equipment.

According to the National Psoriasis Foundation, around 125 million people globally suffer from psoriasis, which is around 2-3% of the total population. Similarly, according to the National Eczema Association, around 31.6 million people in the U.S. suffer from eczema and one in every ten individuals is anticipated to suffer from eczema once in their lifetime.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Phototherapy treatment is widely recognized as a highly beneficial approach for addressing neonatal jaundice. This therapeutic method involves subjecting newborns to fluorescent light, which accelerates their recovery process. Although jaundice is a common occurrence among infants, persistent cases often require the use of phototherapy devices for treatment. According to the Pediatric Medicine Journal, the incidence of jaundice in newborns ranges from 60% to over 90%. Moreover, the National Health Service estimates that approximately six out of ten babies experience jaundice, while the risk of jaundice rises to eight out of ten for premature infants.

The implementation of phototherapy in neonatal care offers several advantages, including reduced healthcare costs and the ability to keep infants and their families together during the treatment process. In January 2026, the U.S. FDA granted 510(k) clearance to TheraB Medical’s SnugLit Wearable Phototherapy System, a wearable device designed to treat neonatal jaundice in both hospital and home settings. The clearance supports broader adoption of family-centered phototherapy by enabling effective treatment while allowing infants to remain with their caregivers. The device used for this purpose delivers high-intensity phototherapy, comparable to the treatments administered in neonatal intensive care units (NICU). Furthermore, the gadget is designed to be mobile, portable, and lightweight, allowing it to operate on batteries. It can be easily cleaned using standard hospital sanitizing chemicals, making it suitable for use in various settings, including hospitals, homes, and even resource-limited or rural areas.

Analyst Perspective

The phototherapy devices market is witnessing steady growth, driven by the rising prevalence of neonatal jaundice and chronic skin disorders such as psoriasis, vitiligo, and eczema. Increasing adoption of portable, LED-based, and home-use phototherapy systems is expanding access to treatment. Despite challenges related to reimbursement, regulatory requirements, and high costs, continued product innovation and broader geographic expansion are expected to support long-term market growth.

Product Insights

The LED-based phototherapy segment dominated the market with the largest revenue share of 48.0% and is expected to grow at the fastest CAGR during the forecast period from 2026 to 2033. LED based phototherapy is used to treat skin diseases and concerns such as fine lines, psoriasis, and acne. The rise in the number of people suffering from such skin conditions is expected to boost the demand for LED-based phototherapy devices. For instance, according to MDALGORITHMS INC., 85% of people experience acne at some point in their life.

Moreover, nearly 50 million people in the U.S. are anticipated to suffer from acne, out of which 15% suffer from acne which can result in scarring. In addition, according to an article published by the National Library of Medicine, infrared light therapy can improve and reduce fine lines & wrinkles. The increasing number of people suffering from fine lines & wrinkles is expected to help the segment growth. For instance, a 2025 American Academy of Dermatology survey found that 4 in 10 U.S. adults reported wrinkles or dark caused by sun exposure, and 68.0% of those individuals were bothered by such changes in skin health. Growing awareness about conditions, information availability and skin health education initiatives by various organizations are likely to present novel opportunities for related treatments, leading to growth in demand for LED-based phototherapy equipment.

The conventional phototherapy equipment segment is expected to grow at a lucrative CAGR during the forecast period from 2026 to 2033. Conventional phototherapy equipment is used for the treatment of jaundice, as it helps in reducing bilirubin levels in neonates. The rising incidence of newborns suffering from jaundice is anticipated to help the segment propel during the forecast period. For instance, according to the March of Dimes Organization, around 3 in every 5 babies (around 60.0%) suffer from jaundice. Similarly, according to Medscape, it is estimated that 80.0% of pre-term babies are expected to develop jaundice within 2-4 days. Therefore, the increasing number of pre-term babies is further expected to help the segment's growth.

Application Insights

The skin disease segment dominated the market with the largest revenue share of more than 67.0% in 2025. This is accredited to a rise in the number of various skin diseases such as acne, vitiligo, and others. Vitiligo, a condition in which the skin loses its pigment cells, is becoming dormant in various regions globally. For instance, according to the National Library of Medicine, India is predicted to have an incidence rate of 8.8%, whereas, the same for Mexico was estimated to be 2.6% to 4.0%. As phototherapy has been shown to stop/slow down the progression of vitiligo, its use is expected to increase. Hence, due to the above-mentioned factors, the phototherapy equipment market is estimated to expand during the projected period.

The neonatal jaundice management segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing infant population and rising incidences of neonatal jaundice globally. For instance, according to an article by BMJ Publishing Group & Royal College of Paediatrics and Child Health, neonatal jaundice is extremely common in the UK, where phototherapy is used to treat around 5-10% of babies born at term.

End-use Insights

The hospital segment dominated the market with the largest revenue share of more than 82.0% in 2025. This can be attributed to the increasing number of hospitals worldwide. For instance, the total number of hospital beds across the entire UK has risen to approximately 166,296 beds. Similarly, according to the American Health Association, the number of hospitals in the U.S. is over 6,000. Moreover, according to a study conducted by NCBI, the prevalence of neonatal jaundice at a National District Hospital, Bloemfontein, was calculated to be 55.2%. Hence, owing to the aforementioned factors, the segment is anticipated to propel during the forecast period.

The homecare segment is expected to grow at the fastest CAGR during the forecast period. This can be credited to the availability of phototherapy equipment for homecare settings, and rising awareness about phototherapy equipment among the common population. Moreover, according to the National Psoriasis Foundation, treatment of psoriasis with a home UVB phototherapy can be convenient and economical. Similarly, according to The Royal Women’s Hospital, phototherapy is a safe & convenient option to treat neonatal jaundice in a homecare setting. Hence, the segment is projected to experience lucrative growth in the forecast duration.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 39.0% in 2025. The rising number of various skin conditions such as vitiligo, psoriasis, eczema, and acne is expected to help the region dominate the phototherapy equipment market. According to a 2025 survey by the American Academy of Dermatology Association, approximately 50% of U.S. adults report concern about premature skin aging, while around 4 in 10 individuals notice visible signs such as wrinkles or dark spots linked to sun exposure, highlighting rising consumer awareness of skin appearance and aging-related conditions.

To learn more about this report, Download Free Sample Report

Asia Pacific Phototherapy Equipment Market Trends

The Asia Pacific region is projected to witness the fastest CAGR during the forecast period. The increase in the number of births of pre-term babies and the number of people suffering from skin disorders can be accredited to the high growth rate. In addition, people in the Asia Pacific are prone to acne, which is further expected to propel the use of phototherapy equipment. Increasing investments in improvement of healthcare infrastructure and growing expenditure on skin health primarily contribute to growth in market.

Key Phototherapy Equipment Market Company Insights

The phototherapy equipment market comprises several small and large manufacturers. The degree of competition and competitive rivalry in the market is anticipated to intensify in the forecast period. Major companies are focusing on clinical trials, mergers and acquisitions, product launches, and geographic expansion to have a competitive edge over others.

Key Phototherapy Equipment Companies

The following key companies have been profiled for this study on the phototherapy equipment market:

• Signify Holding

• GE HealthCare

• Natus Medical Incorporated

• Herbert Waldmann GmbH & Co. KG

• Nice Neotech Medical Systems Pvt. Ltd.

• ATOM MEDICAL Corp.

• Phoenix Medical Systems

• Phothera Phototherapy

• Solarc Systems Inc.

• The Daavlin Company

Recent Developments

• In May 2025, Sun Pharmaceutical Industries Limited announced that it has received approval from the U.S. Food and Drug Administration (FDA) for an LED-based device used in combination with LEVULAN KERASTICK for the treatment of minimally to moderately thick actinic keratosis. Featuring a more compact design and flexible panel shape, the BLU-U Blue Light Photodynamic Therapy (PDT) Illuminator is expected to strengthen its portfolio.

• In February 2026, Natus Sensory acquired a developer of wearable neonatal phototherapy solutions, TheraB Medical. Expanding its newborn care solutions, acquisition strengthened its access to SnugLit, wearable phototherapy device for neonatal jaundice.

Global Phototherapy Equipment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global phototherapy equipment market based on product, application, end use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Conventional Phototherapy Equipment

    • Conventional Phototherapy Equipment with Fluorescent Lamp

    • Conventional Phototherapy Equipment with Compact Fluorescent Lamp

  • LED Phototherapy Equipment

  • Fiber Optic Phototherapy Equipment

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Skin Disease Treatment

    • Psoriasis

    • Vitiligo

    • Eczema

    • Others

  • Neonatal Jaundice Management

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics

  • Homecare

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait